Cargando…

Massive Haemoptysis Treated with Bronchial Artery Embolisation in COVID-19 Infection

BACKGROUND: Massive haemoptysis is a rare symptom ofcoronavirus disease 2019 (COVID-19). Management can be very challenging due to the lack of clear recommendations. CASE DESCRIPTION: We report a case of massive recurrent haemoptysis in a young patient who tested positive for COVID-19 with successfu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mejri, Islam, Boubaker, Nouha, Znegui, Tasnim, Daboussi, Selsabil, Aichaouia, Chiraz, Mhamdi, Samira, Moatemri, Zied
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451510/
https://www.ncbi.nlm.nih.gov/pubmed/36093306
http://dx.doi.org/10.12890/2022_003475
Descripción
Sumario:BACKGROUND: Massive haemoptysis is a rare symptom ofcoronavirus disease 2019 (COVID-19). Management can be very challenging due to the lack of clear recommendations. CASE DESCRIPTION: We report a case of massive recurrent haemoptysis in a young patient who tested positive for COVID-19 with successful management using endovascular embolization. DISCUSSION: Life-threatening massive haemoptysis has rarely been reported as the only manifestation of COVID-19. Embolisation was the therapeutic option chosen to manage this emergency. LEARNING POINTS: Haemoptysis is a rare atypical presentation that can reveal COVID-19, highlighting the complexity of its pathogenesis. Atypical manifestations should raise suspicion for COVID-19. In this patient with COVID-19, life-threatening massive haemoptysis was successfully treated with endovascular embolisation.